Ringaskiddy, Ireland
GE Healthcare is planning to create a $167 million biopharmaceutical manufacturing campus in Ringaskiddy, Ireland. Featuring GE's prefabricated KUBio™ facilities, GE BioPark Cork will include four KUBio factories owned by independent biopharma companies. GE will manage the campus as well as providing centralized shared utilities and site services. Construction is expected to begin in mid-2017. Additionally, GE is partnering with the National Institute for Bioprocessing Research and Training (NIBRT) at University College Dublin to establish the Single-use Centre of Excellence for the training of bioprocessing professionals.
Source
